NYSE-Euronext a publié un communiqué de presse dans lequel il annonce la nomination d' Alan Whiting à la présidence de Nyse Liffe.
Alan Whiting succèdera à Hugh Freedber.
La nomination de M. Whiting prendra effet au 1er mai 2012.
London, Tuesday 3 April 2012 – NYSE Liffe today announced that Alan Whiting will succeed Hugh Freedberg as the new non-executive Chairman1 of the company’s global derivatives business. Mr Whiting’s appointment will take effect from May 1, 2012. Mr Freedberg who previously served as CEO of NYSE Liffe from 1998 to 2009 is retiring from his role as Chairman, which he has held since 2009.
“I would like to thank Hugh Freedberg for his long and distinguished service to the company and industry as a whole. Amongst his many achievements, Hugh led the reinvention of the company, transforming the business from a mutual in the late nineties. He implemented the company’s state-of-the-art global electronic trading system, was instrumental in the successful merger with Euronext and, in 2011, was installed into the Futures Industry Association’s Hall of Fame.” said Garry Jones, Group EVP and Head of Global Derivatives. “I am extremely pleased that Alan, with such excellent credentials and knowledge of the financial services industry, has accepted the position of non-executive Chairman. Alan has been a member of the NYSE Liffe Board since 2006 and I look forward to working with him as we seek to develop our business further in the future.”
Télécharger le document